Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 4, 2004, Pages 425-431

  Melo, N R ^a,c   Taguchi, H ^b   Jorge, J ^a   Pedro, R J ^a   Almeida, O P ^a   Fukushima, K ^b   Nishimura, K ^b   Miyaji, M ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b CHIBA UNIVERSITY   (Japan)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Antifungal drug; Brazil; Candida; Human immunodeficiency virus

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; DIDANOSINE; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; LAMIVUDINE; MICONAZOLE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KEFYR; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; OPPORTUNISTIC INFECTION; SALIVA; THRUSH;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA INTERMEDIA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; HUMAN IMMUNODEFICIENCY VIRUS; KLUYVEROMYCES MARXIANUS; PICHIA GUILLIERMONDII; RHODOTORULA MUCILAGINOSA;

EID: 3242733341     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000400014     Document Type: Article

References (40)

1. Arribas JR, Hernandez-Albujar S, Gonzalez-Garcia JJ, Pena JM, Gonzalez A, Canedo T, Madero R, Vazquez JJ, Powderly WG 2000. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 4: 979 -85.
2. Barchiesi F, Maracci M, Radi B, Arzeni D, Baldassarri I, Giacometti A, Scalise G 2002. Point prevalence, microbiology and fluconazole susceptibility patterns of yeast isolates colonizing the oral cavities of HIV-infected patients in the era of highly active antiretroviral therapy. J Antimicrob Chemother 50: 999-1002.
3. Beighton DRL, Clark DT, Brailsford SR, Pankhurst CL, Tinsley GF, Fiske J, Lewis D, Daly B, Khalifa N 1995. Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 33: 3025-3027.
4. Billon-Grand G 1987. Minor ubiquinones of the yeast coenzime Q system: importance in the taxonomy of the yeast. J Gen Microbiol 33: 381-390.
5. Cartledge JD, Midgley J, Gazzard BG 1999. Non-albicans oral candidosis in HIV-positive patients. J Antimicrob Chemother 43: 419-22.
6. Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180: 448-53.
7. CDC 1993. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41: 1-19.
8. Colombo AL, Nucci M, Salomao R, Branchini ML, Richtmann R, Derossi A, Wey SB 1999. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 34: 281-286.
9. Diz Dios P, Ocampo A, Otero I, Iglesias I, Martinez C 2001. Changes in oropharyngeal colonization and infection by Candida albicans in human immunodeficiency virus-infected patients. J Infect Dis 183: 355-356.
10. Dronda F, Alonso-Sanz M, Laguna F, Chaves F, Martinez-Suarez JV, Rodriguez-Tudela JL, Gonzalez-Lopez A, Valencia E 1996. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients. Eur J Clin Microbiol & Infect Dis 15: 446-452.
11. Fetter A, Partisani M, Koenig H, Kremer M, Lang JM 1993. Assyntomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors. J Oral Pathol Med 2: 51-9.
12. Fidel PL, Vazquez JrJA, Sobel JD 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 12: 80-96.
13. Fotos PG, Hellstein JW 1992. Candida and candidosis. Epidemiology, diagnosis and therapeutic management. Dent Clin North Am 36: 857-878.
14. Franker CK, Lucartorto FM, Johnson BS, Jacobson JJ 1990. Characterization of the mycoflora from oral mucosal surfaces of some HIV-infected patients. Oral Surg, Oral Med, and Oral Pathol 69: 683-687.
15. Fukuoka T, Johnston DA, Winslow CA, Groot MJ, Burt C, Hitchcock CA, Filler SG 2003. Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei. Antimicrobial Agents and Chemother 47: 1213-19.
16. Fukushima K, Takizawa K, Okada K, Maebayashi Y, Nishimura K, Myiaji M 1993. Suitability of sterilization methods for ubiquinone analysis of pathogenic fungi. Trans Mycol Soc of Japan 34: 473-480.
17. Ghannoum MA, Rice LB 1999. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517.
18. Hauman CH, Thompson IO, Theunissen F, Wolfaardt P 1993. Oral carriage of Candida in healthy and HIV-seropositive persons. Oral Surg, Oral Med, and Oral Pathol 76: 570-572.
19. Korting HC, Schaller M, Eder G, Hamm G, Bohmer U, Hube B 1999. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrobial Agents Chemother 43: 2038-2042.
20. Krcmery V, Barnes AJ 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 50: 243-60.
21. Kurtzman CP, Robnett CJ 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbiol 35: 1216-1223.
22. Le Guennec R, Reynes J, Mallie M, Pujol C, Janbon F, Bastide JM 1995. Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J Clin Microbiol 33: 2732-2737.
23. Mariano P de L, Milan EP, da Matta DA, Colombo AL 2003. Candida dubliniensis identification in Brazilian yeast stock collection. Mem Inst Oswaldo Cruz 98: 533-8.
24. Mata-Essayag S, Magaldi S, Hartung de Capriles C, Deibis L, Verde G, Perez C 2001. "In vitro" antifungal activity of protease inhibitors. Mycopathologia 152: 135-42.
25. NCCLS-National Committee for Clinical Laboratory Standards 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts; document M27-A catalog, Wayne, PA.
26. Nguyen MH, Peacock JEJr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100: 617-623.
27. Nho S, Anderson MJ, Moore CB, Denning DW 1997. Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains. J Clin Microbiol 35: 1036-1039.
28. Odds FC 1984. Ecology and epidemiology of Candida species. Zentralbl Bakteriol A Hyg 257: 207-12.
29. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA 1998. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group. J Clin Microbiol 36: 1886-1889.
30. Pinjon E, Moran GP, Jackson CL, Kelly SL, Sanglard D, Coleman DC, Sullivan DJ 2003. Molecular mechanisms of itra-conazole resistance in Candida dubliniensis. Antimicrobial Agents Chemother 47: 2424-37.
31. Redding SW, Kirkpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson TF 2000. The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients. Spec Care Dentist 20: 178-81.
32. Rodero L, Losso M, Canteros C, Hochenfellner F, Davel G 1998. Candida dubliniensis: 1st isolation in Argentina. Rev Argent Microbiol 30: 39-41.
33. Sandven P 1990. Laboratory identification and sensitivity testing of yeast isolates. Acta Odontol Scand 48: 27-36.
34. Sano A, Vilela MMS, Takahashi I, Fukushima K, Takizawa K, Silva MTN, Uno J, Nishimura K, Miyaji M 2000. Isolation of Candida dubliniensis from the oral cavity of an HIV-positive child from Brazil. Jap J Med Mycol 3: 57-59.
35. Sant'Ana PL, Milan EP, Martinez R, Telles FQ, Ferreira MS, Alcântara AP, Carvalho MT, Colombo AL 2002. Multicenter Brazilian study of oral Candida species isolated from Aids patients. Mem Inst Oswaldo Cruz 97: 253-257.
36. Schoofs AG, Odds FC, Colebunders R, Ieven M, Goossens H 1998. Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses 41: 203-11.
37. Stenderup A 1990. Oral mycology. Acta Odontol Scand 48: 3-10.
38. Sullivan DJ, Westerneng TJ, Heynes KA, Bennet DE, Coleman DC 1995. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1: 1507-1521.
39. Sweet SP 1997. Selection and pathogenicity of Candida albicans in HIV infection. Oral Dis 3 (Suppl. 1): S88-95.
40. Taguchi H, Myiaji M, Nishimura K, Min-Li X 1995. Studies on the synergistic effect of amphotericin B and 5-fluorocytosine on the growth of single hyphae of A. fumigatus a biocell-tracer system. Mycoscience 36: 341-343.